Clinical Endocrinology

Cover image for Clinical Endocrinology

February 2003

Volume 58, Issue 2

Pages 246–245

  1. Letters to the Editors

    1. Top of page
    2. Letters to the Editors
    3. Author's Declaration
    4. Review
    5. Commentary
    6. Original Articles
    1. Different effectiveness of cyproterone acetate doses in treatment of acne (page 246)

      V. De Leo and G. Morgante

      Version of Record online: 5 FEB 2003 | DOI: 10.1046/j.1365-2265.2003.16911.x

  2. Author's Declaration

    1. Top of page
    2. Letters to the Editors
    3. Author's Declaration
    4. Review
    5. Commentary
    6. Original Articles
    1. Molecular analysis of the 21-hydroxylase gene (page 247)

      A. Belgorosky, R. Marino and M. Rivarola

      Version of Record online: 5 FEB 2003 | DOI: 10.1046/j.1365-2265.2003.17092.x

  3. Review

    1. Top of page
    2. Letters to the Editors
    3. Author's Declaration
    4. Review
    5. Commentary
    6. Original Articles
    1. You have free access to this content
      Inhibins and activins: clinical advances in reproductive medicine (pages 115–127)

      Stephen Tong, Euan M. Wallace and Henry G. Burger

      Version of Record online: 5 FEB 2003 | DOI: 10.1046/j.1365-2265.2003.01686.x

  4. Commentary

    1. Top of page
    2. Letters to the Editors
    3. Author's Declaration
    4. Review
    5. Commentary
    6. Original Articles
    1. Radiotherapy in acromegaly: a protagonists viewpoint (pages 128–131)

      J. A. H. Wass

      Version of Record online: 5 FEB 2003 | DOI: 10.1046/j.1365-2265.2003.01706.x

    2. Radiotherapy in acromegaly: the argument against (pages 132–135)

      Ariel L. Barkan

      Version of Record online: 5 FEB 2003 | DOI: 10.1046/j.1365-2265.2003.01704.x

    3. Controversy: radiotherapy for acromegaly (pages 136–137)

      Michael O. Thorner

      Version of Record online: 5 FEB 2003 | DOI: 10.1046/j.1365-2265.2003.01705.x

  5. Original Articles

    1. Top of page
    2. Letters to the Editors
    3. Author's Declaration
    4. Review
    5. Commentary
    6. Original Articles
    1. Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour (pages 141–150)

      C. J. McCabe, J. S. Khaira, K. Boelaert, A. P. Heaney, L. A. Tannahill, S. Hussain, R. Mitchell, J. Olliff, M. C. Sheppard, J. A. Franklyn and N. J. L. Gittoes

      Version of Record online: 5 FEB 2003 | DOI: 10.1046/j.1365-2265.2003.01598.x

      • image
      • image
      • image
      • image
      • image
    2. Promoter mutations are no major cause of PTTG overexpression in pituitary adenomas (pages 151–155)

      D. Kanakis, E. Kirches, C. Mawrin and K. Dietzmann

      Version of Record online: 5 FEB 2003 | DOI: 10.1046/j.1365-2265.2003.01683.x

      • image
      • image
      • image
    3. Diagnosis of growth hormone deficiency after pituitary surgery: the combined acipimox/GH-releasing hormone test (pages 156–162)

      P. Sytze Van Dam, Carlos Dieguez, Fernando Cordido, Wouter R. De Vries, Bernard F. E. Veldhuyzen, E. Van Thiel, Felipe F. Casanueva and Hans P. F. Koppeschaar

      Version of Record online: 5 FEB 2003 | DOI: 10.1046/j.1365-2265.2003.01684.x

      • image
      • image
      • image
    4. Reversal of acromegalic cardiomyopathy in young but not in middle-aged patients after 12 months of treatment with the depot long-acting somatostatin analogue octreotide (pages 169–176)

      Annamaria Colao, Paolo Marzullo, Alberto Cuocolo, Letizia Spinelli, Rosario Pivonello, Domenico Bonaduce, Marco Salvatore and Gaetano Lombardi

      Version of Record online: 5 FEB 2003 | DOI: 10.1046/j.1365-2265.2003.01689.x

      • image
      • image
      • image
    5. Endocrine profiles and semen quality in spinal cord injured men (pages 177–184)

      A. R. Naderi and M. R. Safarinejad

      Version of Record online: 5 FEB 2003 | DOI: 10.1046/j.1365-2265.2003.01693.x

      • image
      • image
    6. Hyperprolactinaemia in hypothyroidism: clinical significance and impact of TSH normalization (pages 185–191)

      Wolfgang Raber, Alois Gessl, Peter Nowotny and Heinrich Vierhapper

      Version of Record online: 5 FEB 2003 | DOI: 10.1046/j.1365-2265.2003.01694.x

      • image
      • image
    7. Facial disfigurement: is it in the eye of the beholder? A study in patients with Graves’ ophthalmopathy (pages 192–198)

      Caroline B. Terwee, Friedo W. Dekker, Gouke J. Bonsel, Siem H. Heisterkamp, Mark F. Prummel, Lelio Baldeschi and Wilmar M. Wiersinga

      Version of Record online: 5 FEB 2003 | DOI: 10.1046/j.1365-2265.2003.01695.x

      • image
    8. Two Italian kindreds with familial hypocalciuric hypercalcaemia caused by loss-of-function mutations in the calcium-sensing receptor (CaR) gene: functional characterization of a novel CaR missense mutation (pages 199–206)

      Filomena Cetani, Elena Pardi, Simona Borsari, Massimo Tonacchera, Eugenia Morabito, Aldo Pinchera and Claudio Marcocci

      Version of Record online: 5 FEB 2003 | DOI: 10.1046/j.1365-2265.2003.01696.x

      • image
      • image
      • image
      • image
    9. Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis (pages 207–212)

      Francesca Sorvillo, Gherardo Mazziotti, Antonella Carbone, Filomena Morisco, Michele Cioffi, Mario Rotondi, Gianfranca Stornaiuolo, Giovanni Amato, Giovanni B. Gaeta, Nicola Caporaso and Carlo Carella

      Version of Record online: 5 FEB 2003 | DOI: 10.1046/j.1365-2265.2003.01697.x

      • image
      • image
    10. Interactions between serum leptin, the insulin-like growth factor-I system, and sex, age, anthropometric and body composition variables in a healthy population randomly selected (pages 213–219)

      José Manuel Gómez, Francisco Javier Maravall, Núria Gómez, Miguel Angel Navarro, Roser Casamitjana and Juan Soler

      Version of Record online: 5 FEB 2003 | DOI: 10.1046/j.1365-2265.2003.01698.x

    11. Both fasting-induced leptin reduction and GH increase are blunted in Cushing's syndrome and in simple obesity (pages 220–228)

      S. Grottoli, C. Gauna, F. Tassone, G. Aimaretti, G. Corneli, Z. Wu, C. J. Strasburger, C. Dieguez, F. F. Casanueva, E. Ghigo and M. Maccario

      Version of Record online: 5 FEB 2003 | DOI: 10.1046/j.1365-2265.2003.01699.x

      • image
      • image
      • image
      • image

SEARCH

SEARCH BY CITATION